title: Emerging role of S-1 in gastric cancer.
abstract: Gastric cancer remains one of the most important malignancies worldwide in terms of incidence and mortality. The treatment is based on the combination of local surgery and radiation therapy as well as systemic chemotherapy and targeted molecules. Fluoropyrimidines and particularly 5-fluorouracil (FU) represent still the backbone for gastric cancer chemotherapy and new molecular versions of this molecule have been brought to clinical practice in order to improve benefits and reduce adverse effects. S-1 is an oral prodrug of 5-FU, which has demonstrated high effectiveness for gastric cancer treatment and a favorable safety profile. Currently, there are geographic differences in the treatment of gastric cancer and in the use of S-1, which is a mainstay of gastric cancer management in Eastern countries, but is not part of the standard care in the rest of the world. In this review, we gathered data from phase I, II, and III trials of S-1 in gastric cancer, in order to define its real benefit-risk ratio and assess whether geographic differences in S-1 use are justified by unchangeable factors.
authors.affiliation: Department of Systems Medicine, Medical Oncology, University of Rome 'Tor Vergata', Tor Vergata Clinical Center, Rome, Italy.
authors.forename: Eriseld
authors.initials: E
authors.lastname: Krasniqi
authors.affiliation: Department of Systems Medicine, Medical Oncology, University of Rome 'Tor Vergata', Tor Vergata Clinical Center, Rome, Italy.
authors.forename: Stefania
authors.initials: S
authors.lastname: Pellicori
authors.affiliation: Department of Systems Medicine, Medical Oncology, University of Rome 'Tor Vergata', Tor Vergata Clinical Center, Rome, Italy.
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Formica
keywords: Gastric cancer treatment; S-1; oral fluoropyrimidines
references.citation: Best Pract Res Clin Gastroenterol. 2006;20(4):633-49
references.pmid: 16997150
references.citation: Jpn J Cancer Res. 1987 Jul;78(7):748-55
references.pmid: 3114201
references.citation: J Clin Oncol. 1998 Jan;16(1):301-8
references.pmid: 9440757
references.citation: Eur J Cancer. 2011 Oct;47(15):2306-14
references.pmid: 21742485
references.citation: Acta Neuropathol. 1990;81(1):66-73
references.pmid: 2128162
references.citation: N Engl J Med. 2008 Jan 3;358(1):36-46
references.pmid: 18172173
references.citation: Lancet. 1996 Apr 13;347(9007):995-9
references.pmid: 8606613
references.citation: Gan To Kagaku Ryoho. 1997 Dec;24(15):2253-64
references.pmid: 9422070
references.citation: Cancer. 1995 Feb 15;75(4):920-5
references.pmid: 7842412
references.citation: Gan To Kagaku Ryoho. 1998 Jul;25(8):1151-8
references.pmid: 9679577
references.citation: Ann Oncol. 2015 Jan;26(1):141-8
references.pmid: 25316259
references.citation: Eur J Surg Oncol. 2004 Apr;30(3):303-8
references.pmid: 15028313
references.citation: J Clin Oncol. 2003 Jun 15;21(12):2282-7
references.pmid: 12805327
references.citation: Ann Surg Oncol. 2014 Jan;21(1):213-9
references.pmid: 23838904
references.citation: Expert Opin Investig Drugs. 2009 Mar;18(3):335-48
references.pmid: 19243284
references.citation: J Clin Oncol. 2010 Mar 20;28(9):1547-53
references.pmid: 20159816
references.citation: J Korean Surg Soc. 2011 Sep;81(3):163-8
references.pmid: 22066117
references.citation: Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4072-6
references.pmid: 15217941
references.citation: Gastric Cancer. 2011 Mar;14 (1):72-80
references.pmid: 21340666
references.citation: Am J Clin Oncol. 1988 Aug;11(4):461-4
references.pmid: 3407626
references.citation: Gastric Cancer. 2014 Jan;17(1):67-75
references.pmid: 23801337
references.citation: Lancet Oncol. 2008 Mar;9(3):215-21
references.pmid: 18282805
references.citation: J Surg Oncol. 2006 Apr 1;93(5):394-400
references.pmid: 16550575
references.citation: Clin Cancer Res. 2004 Aug 1;10(15):4913-21
references.pmid: 15297391
references.citation: Ann Surg Oncol. 2002 Nov;9(9):894-900
references.pmid: 12417512
references.citation: Cancer Res. 1993 Sep 1;53(17):4004-9
references.pmid: 7689420
references.citation: Oncol Rep. 2014 Feb;31(2):613-8
references.pmid: 24317477
references.citation: J Clin Oncol. 1998 Apr;16(4):1490-3
references.pmid: 9552056
references.citation: Gan To Kagaku Ryoho. 2008 Jul;35(7):1147-55
references.pmid: 18633253
references.citation: Clin Cancer Res. 2002 Jul;8(7):2116-22
references.pmid: 12114411
references.citation: Lancet Oncol. 2014 Jan;15(1):78-86
references.pmid: 24332238
references.citation: Gastric Cancer. 2012 Jul;15(3):245-51
references.pmid: 21993850
references.citation: Anticancer Drugs. 1996 Jul;7(5):548-57
references.pmid: 8862723
references.citation: World J Gastroenterol. 2014 Sep 7;20(33):11886-93
references.pmid: 25206296
references.citation: Lancet. 1995 Mar 25;345(8952):745-8
references.pmid: 7891484
references.citation: Cancer Chemother Pharmacol. 2011 Jun;67(6):1423-8
references.pmid: 20809123
references.citation: Cancer Res. 1983 Sep;43(9):4039-44
references.pmid: 6409396
references.citation: Oncology. 2011;80(5-6):296-300
references.pmid: 21778769
references.citation: Anticancer Res. 2013 Apr;33(4):1747-51
references.pmid: 23564827
references.citation: Jpn J Surg. 1981 Mar;11(2):127-39
references.pmid: 7300058
references.citation: World J Surg Oncol. 2013 Nov 01;11:287
references.pmid: 24180462
references.citation: J Clin Oncol. 2005 Oct 1;23(28):6957-65
references.pmid: 16145066
references.citation: Br J Cancer. 2014 Mar 4;110(5):1163-8
references.pmid: 24473399
references.citation: Int J Clin Exp Pathol. 2014 Jun 15;7(7):4274-9
references.pmid: 25120809
references.citation: Oncology. 2000 Apr;58(3):191-7
references.pmid: 10765119
references.citation: Gastric Cancer. 2013 Apr;16(2):133-9
references.pmid: 22527186
references.citation: Gastric Cancer. 2011 Aug;14(3):274-8
references.pmid: 21461654
references.citation: Lancet. 2012 Jan 28;379(9813):315-21
references.pmid: 22226517
references.citation: Cancer Res. 1994 Mar 15;54(6):1507-10
references.pmid: 8137256
references.citation: Ann Surg Oncol. 2009 Dec;16(12):3227-36
references.pmid: 19777180
references.citation: Lancet. 2014 Jan 4;383(9911):31-9
references.pmid: 24094768
references.citation: Eur J Cancer. 1998 Oct;34(11):1715-20
references.pmid: 9893658
references.citation: Lancet Oncol. 2014 Jul;15(8):886-93
references.pmid: 24954805
references.citation: Gastrointest Cancer Res. 2008 Jul;2(4):187-97
references.pmid: 19259285
references.citation: Zhonghua Wei Chang Wai Ke Za Zhi. 2011 Feb;14(2):104-6
references.pmid: 21365500
references.citation: Gastric Cancer. 2014 Apr;17(2):383-6
references.pmid: 23719867
references.citation: J Clin Oncol. 1996 Dec;14(12):3085-96
references.pmid: 8955653
references.citation: Clin Cancer Res. 2003 Jan;9(1):134-42
references.pmid: 12538461
references.citation: World J Surg. 1993 May-Jun;17(3):410-4; discussion 415
references.pmid: 8337889
references.citation: J Clin Oncol. 2012 Jul 1;30(19):2327-33
references.pmid: 22585691
references.citation: J Clin Oncol. 2011 Nov 20;29(33):4387-93
references.pmid: 22010012
references.citation: Br J Cancer. 2003 Dec 15;89(12):2207-12
references.pmid: 14676796
references.citation: Mol Clin Oncol. 2014 Jan;2(1):93-98
references.pmid: 24649314
references.citation: Radiat Oncol. 2014 Jan 08;9:9
references.pmid: 24398302
references.citation: Cancer Treat Rep. 1979 Mar;63(3):343-50
references.pmid: 371796
references.citation: Nature. 1957 Mar 30;179(4561):663-6
references.pmid: 13418758
references.citation: N Engl J Med. 2001 Sep 6;345(10):725-30
references.pmid: 11547741
references.citation: J Clin Oncol. 2000 Jul;18(14):2772-9
references.pmid: 10894878
references.citation: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references.pmid: 21296855
references.citation: Gan To Kagaku Ryoho. 2012 Nov;39(12):2310-2
references.pmid: 23268060
references.citation: Clin Cancer Res. 1999 Aug;5(8):2000-5
references.pmid: 10473078
references.citation: World J Gastroenterol. 2010 Sep 28;16(36):4575-82
references.pmid: 20857529
references.citation: Gan To Kagaku Ryoho. 2013 Nov;40(12):2217-9
references.pmid: 24394064
references.citation: Cancer Chemother Pharmacol. 2006 Jun;57(6):736-40
references.pmid: 16163539
references.citation: Clin Pharmacol Ther. 2003 Jul;74(1):69-76
references.pmid: 12844137
references.citation: Jpn J Pharmacol. 1980 Dec;30(6):871-9
references.pmid: 7241861
references.citation: Ann Surg Oncol. 2012 Sep;19(9):2937-45
references.pmid: 22466666
references.citation: Cancer. 2007 Jan 1;109(1):33-40
references.pmid: 17133415
references.citation: Lancet Oncol. 2010 May;11(5):439-49
references.pmid: 20409751
references.citation: Gastric Cancer. 2014 Apr;17(2):348-53
references.pmid: 23736741
references.citation: N Engl J Med. 2006 Jul 6;355(1):11-20
references.pmid: 16822992
references.citation: Ann Surg Oncol. 2015 Sep;22(9):2965-71
references.pmid: 25631065
references.citation: Lancet. 2010 Aug 28;376(9742):687-97
references.pmid: 20728210
references.citation: J Surg Oncol. 2012 May;105(6):535-41
references.pmid: 22006649
references.citation: Gan. 1977 Oct;68(5):553-60
references.pmid: 22472
references.citation: Anticancer Res. 2004 May-Jun;24(3b):1843-51
references.pmid: 15274365
references.citation: Ann Oncol. 2004 Sep;15(9):1344-7
references.pmid: 15319239